Riskpilot← Back to searchSign inGet full accessVETSENTRUM AS
ASActiveOrg 827835552Engomsvingen 1, 2323 IngebergVeterinary activities · NACE 7500Est. 202132 employees
Revenue 2024
NOK 22,3M
+10% vs 2023
EBITDA margin
3.1%
-23% vs 2023
Equity ratio
2.8%
Financial strength
Net profit 2024
NOK 80K
-83% vs 2023
| Revenue | NOK 22,3M | +10% |
| EBITDA | NOK 703K | -23% |
| Net profit | NOK 80K | -83% |
| Total assets | NOK 7,5M | +11% |
| Equity | NOK 207K | -94% |
| Employees | 32 | — |
Legal name
VETSENTRUM AS
Org number
827835552
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
29. september 2021
Share capital
NOK 120 000
Employees
32 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Veterinærvirksomhet og annen virksomhet som står i forbindelse med dette.
Address
Engomsvingen 1, 2323 Ingeberg
Phone
+4762509030
Email
info@vetsentrum.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 14 945 | 18 282 | 20 203 | 22 311 |
| Staff expenses | −8 611 | −10 262 | −12 005 | −13 691 |
| EBITDA | 482 | 1 806 | 911 | 703 |
| Depreciation & amort. | −355 | −250 | −312 | −386 |
| EBIT | 127 | 1 556 | 600 | 317 |
| Net financials | −6 | −2 | −7 | −167 |
| Profit before tax | 121 | 1 554 | 593 | 150 |
| Tax | 27 | 342 | 131 | 70 |
| Net profit | 94 | 1 212 | 462 | 80 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 4 478 | 6 110 | 6 722 | 7 452 |
| Equity | 1 994 | 2 940 | 3 402 | 207 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 2 484 | 3 170 | 3 321 | 7 246 |
| Total debt | 2 484 | 3 170 | 3 321 | 7 246 |
EBITDA margin
3.1%
This company
15.8%
Market median
-80% vs market
20212024
Equity ratio
2.8%
This company
38.2%
Market median
-93% vs market
20212024
Return on equity
38.5%
This company
18.4%
Market median
+109% vs market
20212024
Net profit margin
0.4%
This company
8.1%
Market median
-95% vs market
20212024
Asset turnover
2.99×
This company
1.12×
Market median
+167% vs market
20212024
Debt / equity
35.06×
This company
0.62×
Market median
-5555% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-08-20 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LT Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Vet Holding As | Company | 100.0% | 100.0% | 2023 |
Empet As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ax Vi Vet No Holding As
VETSENTRUM AS Board members of VETSENTRUM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Tessem | Chief Executive Officer | 0 companies |
| Eirik Nilssen | Chairman | 0 companies |
| Anne Øverby Øvergaard | Board of Directors | 0 companies |
| Christian Kolthoff | Chairman | 0 companies |